NCT03171493View on ClinicalTrials.gov

Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

February 11, 2021

Study Completion Date

May 12, 2023

Conditions
Urothelial Carcinoma
Interventions
BIOLOGICAL

MV-NIS

Attenuated measles virus encoding NIS (MV-NIS)

Trial Locations (3)

33136

University of Miami, Miami

55905

Mayo Clinic, Rochester

70121

Ochsner Health, New Orleans

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Vyriad, Inc.

INDUSTRY